Complications of intravesical BCG therapy in non-muscle invasive bladder cancer: our tertiary care centre experience

Abstract Background Urothelial bladder carcinoma accounts for around 3.9% cases of all the male cancers in India. Non-muscle-invasive bladder carcinoma (NMIBC) is predominant group which constitute approximately three fourth of the urothelial bladder cancer. Intravesical BCG immunotherapy is the cor...

Descrición completa

Detalles Bibliográficos

Principais autores:	Vivek Sharma, Avinash P. S. Thakur, Vasantharaja Ramasamy, Pushpendra Kumar Shukla, Fanindra Singh Solanki, Arpan Choudhary, Prashant Patel
Formato:	Artigo
Idioma:	Inglês
Publicado:	SpringerOpen 2020-12-01
Series:	African Journal of Urology
Assuntos:	Intravesical BCG Tuberculosis Non-muscle-invasive bladder carcinoma BCG toxicity BCG cystitis
Acceso en liña:	https://doi.org/10.1186/s12301-020-00099-6
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!